News and insights into the #2 pharma/medtech market - China

Greg B. Scott founded ChinaBio® in 2007 to help western life science companies achieve success in China. ChinaBio® is a consulting and advisory firm based in Shanghai that has helped over 100 U.S., European and APAC companies seeking partnerships, acquisitions, novel ... more

ALL CONTRIBUTIONS

Week In Review: Shenzhen's BGI Plans $250 Million China IPO To Support Genomics Operations
Known as a world leader in basic science sequencing, BGI now generates 55% of its income from clinical genomic tests, especially its NIFTY prenatal test for hereditary illnesses such as Down's Syndrome.
Read
Week In Review: IHH Building $1 Billion Of China Hospitals; Seeks Deals For More
This weeks Chinese biotech news features an IPO of Athenex, venture funding for several Chinese medical businesses and successful trials and approvals.
Read
Week In Review: WuXi Biologics Raises $511 Million In Hong Kong IPO
WuXi Biologics priced its Hong Kong IPO at the top of the range, raising $511 million and valuing the biologics operations of WuXi AppTec at $3 billion.
Read
Week In Review: Hong Kong's Cirina Merges With GRAIL For Early Stage Cancer Diagnostics
Cirina, a Hong Kong cancer diagnostics company, will merge with GRAIL, a Menlo Park startup, which is also developing non-invasive early-stage molecular cancer diagnostics.
Read
Week In Review: China Life Science Venture Tie-Up, WuXi And Frontline Merge
Two prominent China-US healthcare investment firms plan to join forces. WuXi Healthcare Ventures and Frontline BioVentures will merge to form 6 Dimensions Capital.
Read
Week In Review: Shanghai Pharma Considers $4 Billion Bid For Germany's Stada
Shanghai Pharma may bid $4 billion to acquire Stada Arzneimittel, a German generic drugmaker. Stada has already accepted a similar offer from a consortium formed by two private equity firms -- Bain and Cinven.
Read

STOCKS I FOLLOW

AXN Aoxing Pharmaceutical Company, Inc.
CRPNF China Pioneer Pharma Holdings Ltd.
CYIG CHINA YCT INTL GROUP
HCM Hutchison Chi-Med
ICLR Icon PLC
MCRPF MICROPORT SCIENTIFIC
MDCO The Medicines Company
MR Mindray Medical International Limited
NBY NovaBay Pharmaceuticals, Inc.
SCLN SciClone Pharmaceuticals, Inc.
WX WuXi PharmaTech Inc.
Load More

TWEETS

LATEST ACTIVITY

ChinaBio® Today
Week in Review: Shenzhen's #BGI Plans $250 Million China #IPO to Support Genomic...

more
ChinaBio® Today
Week In Review: IHH Building $1 Billion Of China Hospitals; Seeks Deals For More $CSL $CSL $LLY $HCM https://t.co/0nH3GnA6LC less
ChinaBio® Today
Week in Review: #WuXi Biologics Raises $511 Million in Hong Kong #IPO more
All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications